Browse
related articles
E-mail warning against medicines 'false'
- United Arab Emirates: Thursday, February 07 - 2008 at 07:57
A UAE Ministry of Health official is condemning a fake e-mail warning people against popular medicines for colds and flu, reported Gulf News. The e-mail lists Panadol Cold and Flu, Advil Cold and Sinus, Clarinase and the generic medicine Flutab by Julphar as banned, citing a fake letter from the Saudi Ministry of Health, for causing heart and mental problems. These medicines are sold over the counter in the UAE and are popular options for people seeking relief from cold and flu symptoms.
Also consider reading:
Today's top stories
Week's top stories
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
- » Landmark Advisory's Developer Rating indicates deficit of Grade A developers in Dubai and Abu Dhabi
- » Starcom Mediavest Group continues award winning success at Mena Cristal Awards
- » New 2010 Hyundai Tucson expected to take UAE market by storm
- » Clemenceau Medical Center (CMC) amongst top ten world's best hospitals for medical tourism
- » ADAC, Al Jaber sign tenancy deal
Jeff Florian, Senior ReporterThursday, February 07 - 2008 at 07:57 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.
For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions
It looks like you are using a Mac - check out our 
Web Feeds